M&A Deal Summary |
|
---|---|
Date | 2017-11-27 |
Target | UBC |
Sector | Life Science |
Buyer(s) | Avista Healthcare Partners |
Sellers(s) | Express Scripts Holding |
Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 2005 |
PE ASSETS | 8.0B USD |
Size | Mega |
Type | Sector Focused |
Avista Capital Partners is a private investment firm formed by a group of professionals with roots from DLJ Merchant Banking Partners. Avista makes controlling and minority investments in US based energy, healthcare, and media companies with revenues greater than $25 million. Typical transactions include leverage buyouts, build-ups, and growth capital financings. Avista Capital was formed in 2005 and is based in New York City with an additional office in Houston, Texas.
DEAL STATS | # |
---|---|
Overall | 38 of 54 |
Sector (Life Science) | 8 of 13 |
Type (Divestiture) | 6 of 8 |
State (Pennsylvania) | 3 of 3 |
Country (United States) | 31 of 43 |
Year (2017) | 3 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-10-12 |
OptiNose
Yardley, Pennsylvania, United States OptiNose is a specialty pharmaceutical company focused on the development and commercialization of products for patients cared for by, or in consultation with, ear, nose, and throat (ENT) or allergy specialists. OptiNose was founded in 2000 and is based in Yardley, Pennsylvania. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2018-02-08 |
Zest Dental Solutions
Carlsbad, California, United States Zest Dental Solutions is a provider of dental solutions across a continuum of patient care. Zest is widely known as the global leader in reliable, innovative restorative solutions for the treatment of edentulous patients. In recent years, Zest has strengthened its offering by expanding the breadth of its product portfolio, with acquisitions of restorative consumables and small equipment products. Zest Dental Solutions was founded in 1977 and is based in Carlsbad, California. |
Sell | - |
Category | Company |
---|---|
Founded | 1986 |
Sector | Healthcare Services |
Employees | 25,900 |
Revenue | 100.1B USD (2017) |
Express Scripts Holding Co. is a provider of integrated pharmacy-benefit management services. Services include network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. Express Scripts Holding Co. was formed in 1986 and is based in St. Louis, Missouri.
DEAL STATS | # |
---|---|
Overall | 4 of 4 |
Sector (Life Science) | 1 of 1 |
Type (Divestiture) | 4 of 4 |
State (Pennsylvania) | 1 of 1 |
Country (United States) | 3 of 3 |
Year (2017) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-10-10 |
EviCore Healthcare
Bluffton, South Carolina, United States eviCore offers proven, diversified medical benefits management solutions that help clients reduce costs while increasing quality of care for their members. The company provides these solutions to managed care organizations and risk-bearing provider organizations serving commercial, Medicare, and Medicaid populations. Powered by a team of specialized medical professional resources, extensive evidence-based guidelines, and advanced technologies, eviCore supports clients by ensuring the right evidence-based care is delivered at the right time to the right patient at the right site of care. Flexible medical benefits management solutions are offered in: Radiology; Cardiology; Musculoskeletal; Medical Oncology; Radiation Therapy; Specialty Drug Management; Sleep; Lab Management; and Post-Acute Care. eviCore is proud to help 100 million members receive higher quality, lower cost healthcare. |
Buy | $3.6B |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-10-02 |
Verity Solutions Group
Kirkland, Washington, United States Verity Solutions is a provider of software and services developed for administration of the federal 340B drug pricing program. The Company simplifies the complex process of maintaining 340B PROGRAM compliance resulting in critical 340B cost savings for our customers. |
Buy | - |